跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
那西妥单抗注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Naxitamab Injection
Approved
生物制品
Naxitamab Injection
Y-mAbs Therapeutics
🇨🇳 National Medical Products Administration
Approval Date
Nov 30, 2022
Approval ID
a1eb7f5440a06b4f
Company
Y-mAbs Therapeutics
Type
生物制品
Approval Details
Approval Id
a1eb7f5440a06b4f
Approval Number
国药准字SJ20220019
Generic Name
那西妥单抗注射液
Generic Name En
Naxitamab Injection
Drug Type
生物制品
Dosage Form
注射剂
Strength
40mg(10mL)/瓶
Reg Date
2022-11-30
Expired Date
2027-11-29
Company Name
Y-mAbs Therapeutics
Production Company Name
Patheon Manufacturing Services LLC
Company Detail Path
/organization/y-mabs-therapeutics
Production Company Detail Path
/organization/patheon-manufacturing-services-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 30, 2022
Approval ID
a1eb7f5440a06b4f
Type
生物制品
Back to NMPA Approvals